NCT02038972View on ClinicalTrials.gov

Safety of Autologous Stem Cell Infusion for Children With Acquired Hearing Loss

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

December 11, 2015

Study Completion Date

January 10, 2017

Conditions
Sensorineural Hearing Loss
Interventions
GENETIC

Autologous Stem Cells

The subjects autologous stem cells banked at Cord Blood Registry will be infused intravenously by gravity.

Trial Locations (1)

32803

Florida Hospital, Orlando

Sponsors

Collaborators (1)

CBR Systems, Inc.
All Listed Sponsors
collaborator

CBR Systems, Inc.

OTHER

lead

James Baumgartner, MD

OTHER

NCT02038972 - Safety of Autologous Stem Cell Infusion for Children With Acquired Hearing Loss | Biotech Hunter | Biotech Hunter